نتائج البحث - Gavin Halbert

  • يعرض 1 - 13 نتائج من 13
تنقيح النتائج
  1. 1
    Immunohistochemical staining for adipophilin, perilipin and TIP47

    Immunohistochemical staining for adipophilin, perilipin and TIP47 حسب Kirithika Muthusamy, Gavin Halbert, Fiona Roberts

    منشور في 2006
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs

    Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs حسب Ibrahim Khadra, Zhou Zhou, Claire Dunn, Clive Wilson, Gavin Halbert

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs

    Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs حسب Zhou Zhou, Claire Dunn, Ibrahim Khadra, Clive Wilson, Gavin Halbert

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    A novel hot-melt extrusion formulation of albendazole for increasing dissolution properties

    A novel hot-melt extrusion formulation of albendazole for increasing dissolution properties حسب Laura Martinez‐Marcos, Dimitrios A. Lamprou, Roy T. McBurney, Gavin Halbert

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics

    Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics حسب Carla B. Roces, Gustavo Lou, Nikita Jain, Suraj Abraham, A.M. Thomas, Gavin Halbert, Yvonne Perrie

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Characterisation and optimisation of diclofenac sodium orodispersible thin film formulation

    Characterisation and optimisation of diclofenac sodium orodispersible thin film formulation حسب Ibrahim Khadra, Mohammad A. Obeid, Claire Dunn, Stewart Ian Watts, Gavin Halbert, Steve Ford, Alexander B. Mullen

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer

    Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer حسب Sarah Danson, D. Ferry, Valery Yu. Alakhov, J. Margison, David J. Kerr, Debra Jowle, M Brampton, Gavin Halbert, Malcolm Ranson

    منشور في 2004
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic study

    5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic study حسب Gordon Rustin, Christopher Bradley, Susan Galbraith, M.R.L. Stratford, Paul M. Loadman, S. Waller, K Bellenger, Lindsey Gumbrell, Lisa K. Folkes, Gavin Halbert

    منشور في 2003
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer

    Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer حسب Anne O’Donnell, Ian Judson, Mitch Dowsett, Florence I. Raynaud, David P. Dearnaley, M. Mason, S.J. Harland, Alissa K. Robbins, Gavin Halbert, Bernard Nutley, Michael Jarman

    منشور في 2004
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent

    Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent حسب Michael B. Jameson, Paul Thompson, Bruce C. Baguley, B D Evans, V.J. Harvey, David Porter, Michael R. McCrystal, Maurice J. Small, K Bellenger, Lindsey Gumbrell, Gavin Halbert, P. Kestell

    منشور في 2003
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Lomeguatrib, a Potent Inhibitor of <i>O</i>6-Alkylguanine-DNA-Alkyltransferase: Phase I Safety, Pharmacodynamic, and Pharmacokinetic Trial and Evaluation in Combination with Temozolomide in Patients with Advanced Solid Tumors

    Lomeguatrib, a Potent Inhibitor of <i>O</i>6-Alkylguanine-DNA-Alkyltransferase: Phase I Safety, Pharmacodynamic, and Pharmacokinetic Trial and Evaluation in Combination with Temozo... حسب Malcolm Ranson, Mark R. Middleton, John Bridgewater, Siow Ming Lee, Martin D. Dawson, Debra Jowle, Gavin Halbert, S. Waller, Helen E. McGrath, Lindsey Gumbrell, R. Stanley McElhinney, Dorothy J. Donnelly, T. Brian H. McMurry, Geoffrey P. Margison

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors

    First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors حسب Robert McLeod, Rajiv Kumar, Dionysis Papadatos-Pastos, Joaquı́n Mateo, Jessica Brown, Alvaro Ingles Garces, Ruth Ruddle, Shaun Decordova, Simone Jueliger, Roberta Ferraldeschi, Óscar Maiques, Victoria Sanz‐Moreno, Paul S. Jones, Stephanie Traub, Gavin Halbert, Sarah Mellor, Karen E. Swales, Florence I. Raynaud, Michelle D. Garrett, Udai Banerji

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs

    Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs حسب Simon Eschweiler, Ciro Ramírez-Suástegui, Yingcong Li, Emma V. King, Lindsey Chudley, Jaya Thomas, Oliver Wood, Adrian von Witzleben, D. Lifson Jeffrey, Katy J. McCann, Hayley Simon, Monalisa Mondal, Alice Wang, Martina Dicker, Elena Lopez-Guadamillas, Ting-Fang Chou, Nicola Dobbs, Louisa Essame, Gary D Acton, Fiona Kelly, Gavin Halbert, Joseph J. Sacco, Andrew Schache, Richard Shaw, James McCaul, Claire Paterson, Joseph H. Davies, Peter A. Brennan, Rabindra Prasad Singh, Paul M. Loadman, William Wilson, Allan Hackshaw, Grégory Seumois, Klaus Okkenhaug, Gareth J. Thomas, Terry M. Jones, Ferhat Ay, Greg Friberg, Mitchell Kronenberg, Bart Vanhaesebroeck, Pandurangan Vijayanand, Christian H. Ottensmeier

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: